- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Intech Biopharm Ltd (6461)
Intech Biopharm Ltd stock price live, this page displays TWO 6461 stock exchange data. View the 6461 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Intech Biopharm Ltd real time stock price chart below.
What Is the Intech Biopharm Ltd Stock Price Today?
The Intech Biopharm Ltd stock price today is 19.70.
What Is the Stock Symbol for Intech Biopharm Ltd?
The stock symbol for Intech Biopharm Ltd is ""6461.""
What Stock Exchange Does Intech Biopharm Ltd Trade On?
Intech Biopharm Ltd is listed and trades on the TPEX stock exchange.
Is Intech Biopharm Ltd a Good Stock to Buy?
Determining whether Intech Biopharm Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6461 quote. (ISIN: TW0006461007)
What Is the Intech Biopharm Ltd Stock Price Today?
The Intech Biopharm Ltd stock price today is 19.70.
What Is the Stock Symbol for Intech Biopharm Ltd?
The stock symbol for Intech Biopharm Ltd is ""6461.""
What Stock Exchange Does Intech Biopharm Ltd Trade On?
Intech Biopharm Ltd is listed and trades on the TPEX stock exchange.
Is Intech Biopharm Ltd a Good Stock to Buy?
Determining whether Intech Biopharm Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6461 quote. (ISIN: TW0006461007)
TPEX
Currency in TWD
19.70
+0.70(+3.68%)
Closed·
Fair Value
An estimate of a Intech Biopharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.90
19.95
52 wk Range
16.50
34.60
6461 Scorecard
Full Analysis
Suffers from weak gross profit margins
6461 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Intech Biopharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.9019.95
52 wk Range
16.5034.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6461 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Intech Biopharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy
Intech Biopharm Ltd Company Profile
Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.
Compare 6461 to Peers and Sector
Metrics to compare | 6461 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6461PeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.4x | 21.2x | −0.5x | |
PEG Ratio | 1.69 | 0.22 | 0.00 | |
Price/Book | 4.4x | 4.4x | 2.6x | |
Price / LTM Sales | 98.3x | 3.9x | 3.3x | |
Upside (Analyst Target) | - | 16.4% | 45.4% | |
Fair Value Upside | Unlock | 11.3% | 7.7% | Unlock |
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-0.64 / --
Revenue / Forecast
7.66M / --
FAQ
What Stock Exchange Does Intech Biopharm Trade On?
Intech Biopharm is listed and trades on the Taipei Exchange stock exchange.
What Is the Stock Symbol for Intech Biopharm?
The stock symbol for Intech Biopharm is "6461."
What Is the Intech Biopharm Market Cap?
As of today, Intech Biopharm market cap is 3.21B.
What Is Intech Biopharm's Earnings Per Share (TTM)?
The Intech Biopharm EPS (TTM) is -2.78.
From a Technical Analysis Perspective, Is 6461 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Intech Biopharm Stock Split?
Intech Biopharm has split 2 times.
How Many Employees Does Intech Biopharm Have?
Intech Biopharm has 90 employees.
What is the current trading status of Intech Biopharm (6461)?
As of 03 Aug 2025, Intech Biopharm (6461) is trading at a price of 19.70, with a previous close of 23.25. The stock has fluctuated within a day range of 18.90 to 19.95, while its 52-week range spans from 16.50 to 34.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.